Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jessica R Flynn (Jessica Flynn)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Venues

Blood advances

JCO precision oncology

JCO oncology practice

Cancer

Memorial Sloan Kettering Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan Kettering Cancer Center Jun 26o 2017

United States

Data Analyst-002631 :: Dept of epibio - biostats serv

Publications

Jessica R Flynn, Michael Curry, Binsheng Zhao, Hao Yang, Laurent Dercle, Antonio Tito Fojo, Dana E Connors, Lawrence H Schwartz, Mithat Gönen, Chaya S Moskowitz
Modeling Tumor Growth Using Partly Conditional Survival Models: A Case Study in Colorectal Cancer. JCO clinical cancer informatics 7 (2023)
Warren B Fingrut, Stephanie Chinapen, Jessica R Flynn, Angela Katrichis, Melissa Stewart, Eric Davis, Brian C Shaffer, Gunjan L Shah, Juliet N Barker
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood advances (2023)
Roni Tamari, Michael Scordo, Binni Kunvarjee, Anthony Proli, Andrew Lin, Jessica R Flynn, Christina Cho, Sean M Devlin, Elizabeth Klein, Farid Boulad, Maria I Cancio, Kevin J Curran, Ann A Jakubowski, Nancy A Kernan, Andrew L Kung, Richard J O'Reilly, Esperanza B Papadopoulos, Susan E Prockop, Andromachi Scaradavou, Brian C Shaffer, Gunjan L Shah, Barbara Spitzer, Boglarka Gyurkocza, Sergio A Giralt, Miguel-Ángel Perales, Jaap-Jan Boelens
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation. Blood advances (2023)
Warren B Fingrut, Stephanie Chinapen, Jessica R Flynn, Angela Katrichis, Melissa Stewart, Eric Davis, Brian C Shaffer, Gunjan L Shah, Juliet N Barker
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood advances (2023)
Warren B Fingrut, Stephanie Chinapen, Jessica R Flynn, Angela Katrichis, Melissa Stewart, Eric Davis, Brian C Shaffer, Gunjan L Shah, Juliet N Barker
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood advances (2023)
Michael Scordo, Jessica R Flynn, Mithat Gönen, Sean M Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L Porter, Stephen J Schuster, Veronika Bachanova, Joseph Maakaron, Richard T Maziarz, Andy I Chen, Loretta J Nastoupil, Joseph P McGuirk, Olalekan O Oluwole, Andrew Ip, Lori A Leslie, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Identifying an Optimal Fludarabine Exposure for Improved Outcomes after CD19 CAR T cell therapy for Aggressive B-NHL. Blood advances (2023)
Warren B Fingrut, Stephanie Chinapen, Jessica R Flynn, Angela Katrichis, Melissa Stewart, Eric Davis, Brian C Shaffer, Gunjan L Shah, Juliet N Barker
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood advances (2023)
Warren B Fingrut, Boglarka Gyurkocza, Jessica R Flynn, Eric Davis, Sean M Devlin, Andromachi Scaradavou, Stephanie Chinapen, Sean Quach, Christina Cho, Sergio A Giralt, Ann A Jakubowski, Richard J Lin, Esperanza B Papadopoulos, Miguel-Ángel Perales, Doris M Ponce, Brian Shaffer, Roni Tamari, James W Young, Ioannis Politikos, Juliet N Barker
Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia. Blood advances (2022)
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, Sean M Devlin, Jamie Brower, Veronika Bachanova, Loretta J Nastoupil, Joseph P McGuirk, Richard T Maziarz, Olalekan O Oluwole, Stephen J Schuster, David L Porter, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy. Blood advances (2022)
Robert M Daly, Kevin J Nicholas, Jessica R Flynn, Katherine S Panageas, Nicholas Silva, Elaine Duck, Alice Zervoudakis, Jessie Holland, Rori Salvaggio, Aaron Begue, Isaac Wagner, Stefania Sokolowski, Melissa Zablocki, Yeneat O Chiu, Gilead J Kuperman, Brett A Simon, Wendy Perchick, Diane L Reidy
Association Between Remote Monitoring and Acute Care Visits in High-Risk Patients Initiating Intravenous Antineoplastic Therapy. JCO oncology practice (2022)
Warren B Fingrut, Boglarka Gyurkocza, Eric Davis, Jessica R Flynn, Stephanie Chinapen, Kristine A Naputo, Sean Quach, Christina Cho, Sergio A Giralt, Ann A Jakubowski, Richard J Lin, Esperanza B Papadopoulos, Miguel-Ángel Perales, Doris M Ponce, Brian C Shaffer, Craig S Sauter, Roni Tamari, James W Young, Andromachi Scaradavou, Ioannis Politikos, Juliet N Barker
Racial disparities in access to alternative donor allografts persist in the era of "donors for all". Blood advances 6 (20) (2022)
Michael Scordo, Leah J Gilbert, Danielle M Hanley, Jessica R Flynn, Sean M Devlin, Linh K Nguyen, Josel D Ruiz, Gunjan L Shah, Craig S Sauter, David J Chung, Heather J Landau, Oscar B Lahoud, Richard J Lin, Parastoo B Dahi, Miguel-Ángel Perales, Sergio A Giralt, Gerald A Soff
Open-Label, Pilot Study of Romiplostim for Thrombocytopenia After Autologous Hematopoietic Cell Transplantation. Blood advances (2022)
Harper G Hubbeling, Noura J Choudhury, Jessica R Flynn, Zhigang Zhang, Christina J Falcon, Valerie W Rusch, Bernard J Park, Etay Ziv, Narek Shaverdian, Daphna Y Gelblum, Annemarie F Shepherd, Charles B Simone, Abraham Jing-Ching Wu, Daniel R Gomez, Alexander E Drilon, Andreas Rimner
Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers. JCO precision oncology 6 (2022)
Carlos Eduardo Correia, Yoshie Umemura, Jessica R Flynn, Anne S Reiner, Edward K Avila
Pharmacoresistant seizures and IDH mutation in low-grade gliomas. Neuro-oncology advances 3 (1) (2021)
Roni Shouval, Ana Alarcon Tomas, Joshua Alexander Fein, Jessica R Flynn, Ettai Markovits, Shimrit Mayer, Aishat Olaide Afuye, Anna Alperovich, Theodora Anagnostou, Michal J Besser, Connie Lee Batlevi, Parastoo B Dahi, Sean M Devlin, Warren B Fingrut, Sergio A Giralt, Richard J Lin, Gal Markel, Gilles Andre Salles, Craig S Sauter, Michael Scordo, Gunjan L Shah, Nishi Shah, Ruth Scherz-Shouval, Marcel van den Brink, Miguel-Ángel Perales, Maria Lia Palomba
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, Mithat Gönen, Xiuyan Wang, Brigitte Senechal, Kevin J Curran, Mikhail Roshal, Peter G Maslak, Mark Blaine Geyer, Elizabeth F Halton, Claudia Diamonte, Marco L Davila, Michel Sadelain, Renier J Brentjens, Jae H Park
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy. Blood 138 (7) (2021)
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Lee Batlevi, Renier J Brentjens, Parastoo Bahrami Dahi, Sean M Devlin, Claudia Diamonte, Sergio A Giralt, Elizabeth F Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S Sauter, Michael Scordo, Gunjan L Shah, Jae H Park, Lucrecia Yáñez, Miguel-Ángel Perales
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood advances 5 (17) (2021)
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, Sandy Badson, Stefan Hamaway, Mrinal M Gounder, Danny N Khalil, Alexander E Drilon, Bob T Li, Komal L Jhaveri, Alison M Schram, Katherine E Kargus, Mary Kate Kasler, Natalie M Blauvelt, Neil H Segal, Marinela Capanu, Margaret K Callahan, David M Hyman, Maya Gambarin-Gelwan, James J Harding
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials. Cancer 126 (22) (2020)

Jessica R Flynn.css-eqlu8i{font-size:small;padding-left:4px;} (Jessica Flynn)

Publication Activity (10 Years)

Top Topics

Top Venues

Jessica R Flynn (Jessica Flynn)